Ally Bridge Group (Ny) LLC Verona Pharma PLC Transaction History
Ally Bridge Group (Ny) LLC
- $69.6 Million
- Q2 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 160,701 shares of VRNA stock, worth $17.2 Million. This represents 21.84% of its overall portfolio holdings.
Number of Shares
160,701
Previous 139,067
15.56%
Holding current value
$17.2 Million
Previous $8.83 Million
72.15%
% of portfolio
21.84%
Previous 11.61%
Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
322Shares Held
76.8MCall Options Held
977KPut Options Held
3.12M-
Janus Henderson Group PLC London, X06.13MShares$655 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$588 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$361 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$326 Million4.43% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.51B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...